Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society
Imaging predictors of the response to transarterial chemoembolization in patients with hepatocellular carcinoma: a radiological-pathological correlation.
Risk of advanced fibrosis with grafts from hepatitis C antibody-positive donors: a multicenter cohort study.
Recipient-donor race mismatch for African American liver transplant patients with chronic hepatitis C.
Effects of ethnicity and socioeconomic status on survival and severity of fibrosis in liver transplant recipients with hepatitis C virus.
Hepatic steatosis at 1 year is an additional predictor of subsequent fibrosis severity in liver transplant recipients with recurrent hepatitis C virus.
Does a patient qualify for liver transplantation after the down-staging of hepatocellular carcinoma?
Mixed hepatocellular cholangiocarcinoma and intrahepatic cholangiocarcinoma in patients undergoing transplantation for hepatocellular carcinoma.
Moderate ascites identifies patients with low model for end-stage liver disease scores awaiting liver transplantation who have a high mortality risk.
Hepatocellular carcinoma: Ablate and wait versus rapid transplantation.
Long-term histological effects of preemptive antiviral therapy in liver transplant recipients with hepatitis C virus infection.
